April 9, 2021
5,365 DEAD 238,949 Injuries: European Database of Adverse Drug Reactions for COVID-19 “Vaccines”
by Brian Shilhavy
Editor, Health Impact News
The European database of suspected drug reaction reports is EudraVigilance, which also tracks reports of injuries and deaths following the experimental COVID-19 “vaccines.”
Here is what EudraVigilance states about their database:
This website was launched by the European Medicines Agency in 2012 to provide public access to reports of suspected side effects (also known as suspected adverse drug reactions). These reports are submitted electronically to EudraVigilance by national medicines regulatory authorities and by pharmaceutical companies that hold marketing authorisations (licences) for the medicines.
EudraVigilance is a system designed for collecting reports of suspected side effects. These reports are used for evaluating the benefits and risks of medicines during their development and monitoring their safety following their authorisation in the European Economic Area (EEA). EudraVigilance has been in use since December 2001.
This website was launched to comply with the EudraVigilance Access Policy, which was developed to improve public health by supporting the monitoring of the safety of medicines and to increase transparency for stakeholders, including the general public.
The Management Board of the European Medicines Agency first approved the EudraVigilance Access Policy in December 2010. A revision was adopted by the Board in December 2015 based on the 2010 pharmacovigilance legislation. The policy aims to provide stakeholders such as national medicines regulatory authorities in the EEA, the European Commission, healthcare professionals, patients and consumers, as well as the pharmaceutical industry and research organisations, with access to reports on suspected side effects.
Transparency is a key guiding principle of the Agency, and is pivotal to building trust and confidence in the regulatory process. By increasing transparency, the Agency is better able to address the growing need among stakeholders, including the general public, for access to information. (Source.)
Their report through March 27, 2021 lists 5,365 deaths and 238,949 injuries following injections of four experimental COVID-19 shots:
- COVID-19 MRNA VACCINE MODERNA (CX-024414)
- COVID-19 MRNA VACCINE PFIZER-BIONTECH
- COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)
- COVID-19 VACCINE JANSSEN (AD26.COV2.S)
A Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. This subscriber has volunteered to do this, and it is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the EudraVigilance system we have found that tabulates all the results.
Hence, by the time we publish these, the stats are already a week old and new stats are already available.
Here is the summary data through March 27, 2021.
Total reactions for the experimental mRNA vaccine Tozinameran (code BNT162b2, Comirnaty) from BioNTech/ Pfizer: 3,268 deaths and 121,514 injuries to 27/03/2021
- 8,979 Blood and lymphatic system disorders incl. 21 deaths
- 5,641 Cardiac disorders incl.368 deaths
- 35 Congenital, familial and genetic disorders incl. 2 deaths
- 3,203 Ear and labyrinth disorders incl. 2 deaths
- 73 Endocrine disorders incl. 1 death
- 3,548 Eye disorders incl. 3 deaths
- 27,477 Gastrointestinal disorders incl. 172 deaths
- 85,398 General disorders and administration site conditions incl. 1,147 deaths
- 138 Hepatobiliary disorders incl. 14 deaths
- 2,426 Immune system disorders incl. 13 deaths
- 7,321 Infections and infestations incl. 332 deaths
- 2,690 Injury, poisoning and procedural complications incl. 49 deaths
- 5,759 Investigations incl. 137 deaths
- 1,926 Metabolism and nutrition disorders incl. 69 deaths
- 44,434 Musculoskeletal and connective tissue disorders incl. 33 deaths
- 80 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 3 deaths
- 53,597 Nervous system disorders incl. 267 deaths
- 120 Pregnancy, puerperium and perinatal conditions incl. 4 deaths
- 62 Product issues
- 4,580 Psychiatric disorders incl. 47 deaths
- 685 Renal and urinary disorders incl. 50 deaths
- 680 Reproductive system and breast disorders incl. 1 death
- 10,717 Respiratory, thoracic and mediastinal disorders incl. 381 deaths
- 12,769 Skin and subcutaneous tissue disorders incl. 26 deaths
- 305 Social circumstances incl. 6 deaths
- 86 Surgical and medical procedures incl. 5 deaths
- 6,039 Vascular disorders incl. 115 deaths
Total reactions for the experimental mRNA vaccine mRNA-1273 (CX-024414) from Moderna: 1,256 deaths and 9,625 injuries to 27/03/2021
- 447 Blood and lymphatic system disorders incl.10 deaths
- 696 Cardiac disorders incl. 124 deaths
- 2 Congenital, familial and genetic disorders
- 168 Ear and labyrinth disorders
- 12 Endocrine disorders
- 277 Eye disorders incl. 2 deaths
- 2,152 Gastrointestinal disorders incl. 43 deaths
- 7,029 General disorders and administration site conditions incl. 548 deaths
- 37 Hepatobiliary disorders incl. 2 deaths
- 287 Immune system disorders incl. 1 death
- 743 Infections and infestations incl. 69 deaths
- 344 Injury, poisoning and procedural complications incl. 21 deaths
- 628 Investigations incl. 40 deaths
- 253 Metabolism and nutrition disorders incl. 22 deaths
- 3,255 Musculoskeletal and connective tissue disorders incl. 25 deaths
- 28 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 3 deaths
- 4,053 Nervous system disorders incl. 138 deaths
- 23 Pregnancy, puerperium and perinatal conditions
- 4 Product issues
- 421 Psychiatric disorders incl. 16 deaths
- 131 Renal and urinary disorders incl. 13 deaths
- 46 Reproductive system and breast disorders incl. 1 death
- 1,140 Respiratory, thoracic and mediastinal disorders incl. 111 deaths
- 1,130 Skin and subcutaneous tissue disorders incl. 13 deaths
- 76 Social circumstances incl. 3 deaths
- 53 Surgical and medical procedures incl. 5 deaths
- 578 Vascular disorders incl. 46 deaths
Total reactions for the experimental vaccine AZD1222 (CHADOX1 NCOV-19) from Oxford/ AstraZeneca: 837 deaths and 107,733 injuries to 27/03/2021
- 2,506 Blood and lymphatic system disorders incl. 33 deaths
- 4,161 Cardiac disorders incl. 104 deaths
- 30 Congenital, familial and genetic disorders incl. 1 death
- 2,569 Ear and labyrinth disorders
- 68 Endocrine disorders incl. 1 death
- 3,936 Eye disorders incl. 2 deaths
- 34,024 Gastrointestinal disorders incl. 34 deaths
- 84,445 General disorders and administration site conditions incl. 307 deaths
- 103 Hepatobiliary disorders incl. 3 deaths
- 1,068 Immune system disorders incl. 2 deaths
- 6,057 Infections and infestations incl. 67 deaths
- 1,870 Injury, poisoning and procedural complications incl. 9 deaths
- 5,338 Investigations incl. 9 deaths
- 4,579 Metabolism and nutrition disorders incl. 7 deaths
- 48,535 Musculoskeletal and connective tissue disorders incl. 7 deaths
- 44 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 2 deaths
- 65,380 Nervous system disorders incl. 105 deaths
- 52 Pregnancy, puerperium and perinatal conditions
- 34 Product issues
- 5,478 Psychiatric disorders incl. 4 deaths
- 984 Renal and urinary disorders incl. 8 deaths
- 723 Reproductive system and breast disorders
- 8,541 Respiratory, thoracic and mediastinal disorders incl. 79 deaths
- 12,726 Skin and subcutaneous tissue disorders incl. 6 deaths
- 189 Social circumstances incl. 2 deaths
- 238 Surgical and medical procedures incl. 8 deaths
- 3,921 Vascular disorders incl. 37 deaths
Total reactions for the experimental COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 4 deaths and 77 injuries to 27/03/2021
(Not enough data to produce a graph yet)
- 9 Cardiac disorders incl. 2 deaths
- 3 Ear and labyrinth disorders
- 7 Eye disorders
- 18 Gastrointestinal disorders
- 49 General disorders and administration site conditions incl. 2 deaths
- 2 Immune system disorders
- 6 Infections and infestations
- 3 Injury, poisoning and procedural complications
- 16 Investigations
- 2 Metabolism and nutrition disorders
- 11 Musculoskeletal and connective tissue disorders
- 42 Nervous system disorders
- 5 Psychiatric disorders
- 1 Renal and urinary disorders
- 2 Reproductive system and breast disorders
- 16 Respiratory, thoracic and mediastinal disorders
- 7 Skin and subcutaneous tissue disorders
- 1 Social circumstances
- 7 Vascular disorders
This is public information funded by the European Medicines Agency (EMA), and anyone can use the EudraVigilance system and verify this data.
These are some serious numbers, and yet we do not know of a single news organization, either corporate media or alternative media, who has published anything on this besides Health Impact News.
Please share this information far and wide, and feel free to copy and republish everything in this report.
Comment on this article at HealthImpactNews.com.
See Also:
No comments:
Post a Comment